Zydus Wellness opened higher at ₹493.90, compared with its previous close of ₹491.85. During today's session, the stock has traded between ₹486.40 and ₹502.80, with an average traded price of ₹495.42. It is currently showing an upward intraday trend.
An investment of ₹10,000 made 5 years ago in Zydus Wellness is now worth
₹ 10,760.00
giving a profit of
₹ 760.00 (7.60%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+7.60 (+1.55%)
Day High
₹502.80
Day Low
₹486.40
Day Open
₹493.90
Prev Close
₹491.85
Volume
67,778
Value Traded
₹3.36 Cr
1W Return
3.23%
1M Return
-9.52%
3M Return
-15.70%
6M Return
1.98%
1Y Return
9.53%
Market Cap (₹ Cr.)
15,891
PE Ratio
83.10
PB Ratio
2.68
Dividend Yield
0.24%
ROE
3.38%
ROCE
3.43%
Book Value (₹)
183.12
Face Value (₹)
2.00
EPS (TTM)
3.74
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
3.23%
6 Week
-
1 Month
-9.52%
3 Month
-15.70%
9 Month
13.18%
Zydus Wellness CMO Arjit Sengupta resigns over personal reasons
Arjit Sengupta resigns as CMO of Zydus Wellness. Departure effective September 18, 2026. Reason cited is personal relocation to Mumbai. Disclosure made under SEBI Regulation 30.
25 days agoZydus Wellness ESG rating rises to 71.7 from 70 in FY25
Zydus Wellness received an ESG score of 71.7 from SES ESG Research. The score improves upon the 70 recorded for Financial Year 2025. Disclosure made under Regulation 30 of SEBI Listing Regulations. Rating assigned voluntarily by SEBI-registered provider SES ESG Research.
1mo agoZydus Wellness to host investors at Anand Rathi G-200 Summit 2026
Zydus Wellness to attend Anand Rathi G-200 Summit 2026. Meeting scheduled for September 22, 2026, in Mumbai. Format includes group sessions and one-on-one interactions. Disclosure made under SEBI LODR Regulation 30.
1mo agoZydus Wellness FY26 Results: Revenue up 46%, debt hits ₹30,711 crore
Revenue rose 46.2% YoY to ₹36,610 million in FY26. EBITDA grew 34.2% to ₹5,097 million. Net profit declined due to higher finance costs and amortization from Comfort Click acquisition. Total borrowings increased to ₹30,711 million, funded at ~5% interest. Board declared a dividend of ₹1.20 per share.
1mo agoZydus Wellness appoints Kapil Sharma as CRO effective September 1, 2026
Zydus Wellness appoints Kapil Sharma as CRO for India and Indian subcontinent. Appointment effective September 1, 2026, approved by Board of Directors. Sharma brings 28+ years experience, including 25 years at P&G. Previously served as VP-Gillette, India and Indian subcontinent.
1mo agoZydus Wellness discloses promoter group share transmission of 27,250 units
Zydus Wellness transmitted 27,250 equity shares to promoter group member Prashant Babubhai Patel. Shares were transferred from the estate of Late Jasodaben Babubhai Patel via off-market transmission. The transaction occurred on August 19, 2026, with no monetary consideration involved. Disclosure filed under SEBI PIT Regulations 2015 on August 24, 2026.
1mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,334.00 | +0.70% | ₹2,57,237.13 | 66.86 | +11.21% | |
| ₹4,801.30 | +0.56% | ₹1,15,648.09 | 44.11 | -18.23% | |
| ₹472.85 | +0.53% | ₹11,856.07 | 46.28 | -35.15% | |
| ₹1,244.50 | -0.07% | ₹8,683.11 | 3.36 | -33.77% | |
| ₹208.93 | +2.47% | ₹6,413.95 | 42.03 | -18.16% | |
| ₹252.45 | -1.02% | ₹3,147.21 | 37.86 | -27.45% | |
| ₹281.15 | -2.51% | ₹3,088.81 | 34.32 | +38.84% | |
| ₹1,041.10 | -0.41% | ₹2,491.35 | 122.35 | +2.57% | |
| ₹9,255.00 | +4.84% | ₹2,374.83 | 62.83 | +4.11% | |
| ₹559.80 | +0.93% | ₹718.84 | 87.65 | -10.01% | |
| ₹161.12 | +3.48% | ₹651.13 | 13.86 | -46.75% | |
| ₹258.95 | +1.17% | ₹642.20 | 117.95 | +11.29% |
An investment of ₹10,000 made 5 years ago in Zydus Wellness is now worth
₹ 10,760.00
giving a profit of
₹ 760.00 (7.60%)
Note: Past profits do not guarantee future returns.
